4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001415889-25-001924
Options or other derivatives
- CHIEF LEGAL OFFICER AND GC acquired 230,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Harsch Mutya · CHIEF LEGAL OFFICER AND GC
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +230,000 | 230,000 | D |
Loading xslF345X05/form4-01232025_040104.xml…